Regulations for Good Clinical Practice Article 10

In the aspect of amount and method of payment to subjects, the sponsor should not impose coercion or undue influences on the trial subjects.The payment to a subject should be prorated and subject to the progress of the trial, instead of payment in full only after completion of the trial.Information regarding payment to subjects, including the methods, amounts, and schedule of payment to trial subjects, should be clearly stated in the written informed consent form and any other written information to be provided to subjects. The way that the payment will be prorated should be specified.